• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NewGen to Exercise Option to Convert Ras Al Khaimah Joint Venture into Joint Development, Projected to Boost Profits from US$67 Million to US$123 Million

    12/12/25 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care
    Get the next $NIVF alert in real time by email

    BANGKOK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced its intention to exercise an option under its joint venture agreement ("JVA") with BNW Real Estate Development LLC ("BNW") to convert the Ras Al Khaimah development project from a Joint Venture structure into a Joint Development structure, while maintaining the existing shareholding of the special purpose vehicle ("SPV").

    This strategic conversion is expected to enhance NewGen's profit entitlement in the flagship Ras Al Khaimah Beach District luxury project, demonstrating its strong confidence in the venture's profitability and commitment to maximizing shareholder returns. Under the Joint Development structure, NewGenProperty Limited, a wholly owned subsidiary of NewGen, shall fully contribute all project finances and will be entitled to 64% of the net profits from the project, potentially increasing the Company's projected pre-tax profit from US$67 million to US$123 million (based on a feasibility analysis by BNW).

    To support the conversion and fund its expanded commitments under the Joint Development structure, NewGen plans to raise additional funds. Any capital raised will further strengthen the Company's financial flexibility as it accelerates project activities and capitalizes on Ras Al Khaimah's rapidly appreciating real estate market.

    Under the relevant clause of the JVA, NewGenProperty Limited, as the Landowner, will assume full responsibility for project financing, including the plot purchase price, development costs, pre-sales expenses, and financial escrow requirements, with any remaining land balance funded through its own resources. BNW, as the Developer, will continue to provide development management services. Following the conversion to the new structure, net profit allocation will shift to 64% for NewGenProperty Limited and 36% for BNW, after deduction of all SPV-related expenses, taxes, and costs.

    The relevant terms of the JVA and the option to convert have been reviewed and endorsed by Ravenscroft & Schmierer, a leading law firm ranked by The Legal 500, which confirmed that NewGen has full legal right to exercise this conversion option in accordance with prevailing laws and the governing terms of the JVA. This endorsement provides additional assurance of the transaction's legality and enforceability.

    The presale phase of the Ras Al Khaimah Beach District project is expected to commence shortly, as it will be permitted once 20% of the land purchase price is paid and all non-financial escrow requirements are fulfilled by the Developer. This milestone, anticipated in the near term, is projected to unlock significant presale proceeds that will help finance ongoing development activities and reduce external funding needs.

    Based on feasibility analyses prepared by BNW, project completion is targeted for 2028, with the revised structure projected to generate an 83% increase in pre-tax profit to NewGen, compared to the original joint venture model.

    Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "Our proposed conversion to a Joint Development structure reaffirms our conviction in the exceptional potential of the Ras Al Khaimah project. With full legal rights confirmed by Ravenscroft & Schmierer, we are proceeding confidently to exercise this option and strengthen our position in one of the UAE's fastest-growing luxury markets. By increasing our profit entitlement to 64% and securing the financial flexibility to drive development, we expect to amplify our share of projected pre-tax profits to US$123 million. With presales launching soon, we anticipate meaningful proceeds that will help fuel construction deliverables and accelerate project momentum, ultimately translating into substantial value creation for our shareholders."

    This conversion provides NewGen with greater strategic control, improved financial participation, and stronger alignment with the project's growth trajectory. The Company continues to seek additional opportunities to expand its real estate portfolio as part of its broader diversification strategy across high-potential GCC markets.

    About NewGenIVF Group Limited

    NewGenIVF Group Limited (NASDAQ:NIVF) is a comprehensive fertility services provider in Asia helping couples and individuals access advanced fertility treatments. With a mission to make parenthood achievable regardless of fertility challenges, NewGen operates fertility centers offering IVF, assisted reproductive technology, gamete donation, and surrogacy services across Thailand, Cambodia, and Kyrgyzstan. Through strategic diversification, NewGen is also building exposure to high-value property developments in growth markets.

    For more information, visit www.newgenivf.com. The information contained on, or accessible through, NewGen's website is not incorporated by reference into this press release.

    Forward-Looking Statements

    This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's intention to exercise the conversion option, plans to raise additional capital, real estate development plans, financial projections (including the projected increase in pre-tax profit from US$67 million to US$123 million), Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as (i) the Company's ability to raise the substantial additional capital required to fund the Joint Development structure on acceptable terms, or at all, and the potential for significant dilution to existing shareholders from any equity financing; (ii) market and economic conditions in the UAE and Ras Al Khaimah real estate markets, including volatility, changes in demand for real estate, and competition from other developments; (iii) construction delays, cost overruns, and our ability to secure required governmental approvals and permits; and (iv) the feasibility analyses and financial projections being based on numerous assumptions that may prove inaccurate, with actual sales prices, sales velocity, and project costs potentially differing materially from projections. The financial projections included in this press release, including the US$67 million and US$123 million pre-tax profit figures, are forward-looking statements [based on feasibility analyses] and numerous assumptions about future events and are inherently uncertain and should not be relied upon as guarantees of future performance. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Company's annual report on Form 20-F and other documents filed or to be filed by the Company with the SEC from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

    Investor Relations Contact:

    ICR, LLC

    Robin Yang

    Phone: +1 (212) 537-3847

    Email: [email protected]



    Get the next $NIVF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NIVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NIVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Chardan Capital Markets Llc claimed ownership of 1,569,000 units of Class A Ordinary Shares (SEC Form 3)

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    11/13/24 9:16:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NewGen to Exercise Option to Convert Ras Al Khaimah Joint Venture into Joint Development, Projected to Boost Profits from US$67 Million to US$123 Million

    BANGKOK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced its intention to exercise an option under its joint venture agreement ("JVA") with BNW Real Estate Development LLC ("BNW") to convert the Ras Al Khaimah development project from a Joint Venture structure into a Joint Development structure, while maintaining the existing shareholding of the special purpose vehicle ("SPV"). This strategic conversion is expected to enhance NewGen's profit entitlement in the flagship Ras Al Khaimah Beach

    12/12/25 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Reports Nine-Month 2025 Results with Balance Sheet Strengthened to $66.75 Net Asset Value Per Share

    BANGKOK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or "the Company"), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today reported its unaudited financial results for the nine months ended September 30, 2025. Financial Highlights for the Nine Months Ended September 30, 2025 Net income attributable to the shareholders of the Company was $17.5 million, a significant improvement from a net loss of $416,400 in the same period of 2024. This was primarily due to a non-cash, bargain purchase gain recognized on the acquisition of Nodexus and Microsort businesses.Basic

    12/2/25 8:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Announces Up to US$2 Million Share Repurchase Program

    BANGKOK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its Board of Directors (the "Board") has authorized a share repurchase program under which the Company may repurchase up to US$2 million of its outstanding Class A ordinary shares over the next 24 months ("Share Repurchase Program"). The Company plans to adopt and implement this Share Repurchase Program in accordance with applicable rules and requirem

    11/10/25 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    SEC Filings

    View All

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    12/2/25 8:01:34 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    11/25/25 4:00:29 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    11/10/25 4:00:19 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    11/13/24 9:19:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    10/10/24 3:39:26 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Leadership Updates

    Live Leadership Updates

    View All

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director

    Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane

    2/20/25 6:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care